These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 17240363)
1. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549). Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669 [TBL] [Abstract][Full Text] [Related]
3. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. Vinodhkumar R; Song YS; Devaki T Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. Ramer R; Hinz B J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069 [TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Chu SC; Chiou HL; Chen PN; Yang SF; Hsieh YS Mol Carcinog; 2004 Jul; 40(3):143-9. PubMed ID: 15224346 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Liu LT; Chang HC; Chiang LC; Hung WC Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate. Kaneko F; Saito H; Saito Y; Wakabayashi K; Nakamoto N; Tada S; Suzuki H; Tsunematsu S; Kumagai N; Ishii H Int J Oncol; 2004 Apr; 24(4):837-45. PubMed ID: 15010820 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228). Sutheesophon K; Nishimura N; Kobayashi Y; Furukawa Y; Kawano M; Itoh K; Kano Y; Ishii H; Furukawa Y J Cell Physiol; 2005 May; 203(2):387-97. PubMed ID: 15515013 [TBL] [Abstract][Full Text] [Related]
10. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820 [TBL] [Abstract][Full Text] [Related]
11. Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro. Lin JP; Yang JS; Wu CC; Lin SS; Hsieh WT; Lin ML; Yu FS; Yu CS; Chen GW; Chang YH; Chung JG In Vivo; 2008; 22(2):223-30. PubMed ID: 18468407 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo. Zhang J; Wang B Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393 [TBL] [Abstract][Full Text] [Related]
13. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells. Sakimura R; Tanaka K; Yamamoto S; Matsunobu T; Li X; Hanada M; Okada T; Nakamura T; Li Y; Iwamoto Y Clin Cancer Res; 2007 Jan; 13(1):275-82. PubMed ID: 17200366 [TBL] [Abstract][Full Text] [Related]
14. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases. Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906 [TBL] [Abstract][Full Text] [Related]
15. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells. Hwang ES; Lee HJ Food Chem Toxicol; 2008 Jul; 46(7):2358-64. PubMed ID: 18502015 [TBL] [Abstract][Full Text] [Related]
16. Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice. Li W; Shen HH Chin Med J (Engl); 2007 Jan; 120(1):5-11. PubMed ID: 17254480 [TBL] [Abstract][Full Text] [Related]
17. Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression. Yan KH; Lee LM; Yan SH; Huang HC; Li CC; Lin HT; Chen PS Chem Biol Interact; 2013 May; 203(3):580-7. PubMed ID: 23566884 [TBL] [Abstract][Full Text] [Related]
18. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679 [TBL] [Abstract][Full Text] [Related]